Jiang Ju, Farris Christina M, Yeh Kenneth B, Richards Allen L
Viral and Rickettsial Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States.
Front Med (Lausanne). 2021 Mar 2;8:622015. doi: 10.3389/fmed.2021.622015. eCollection 2021.
Cooperative research that addresses infectious disease surveillance and outbreak investigations relies heavily on availability and effective use of appropriate diagnostic tools, including serological and molecular assays, as exemplified by the current COVID-19 pandemic. In this paper, we stress the importance of using these assays to support collaborative epidemiological studies to assess risk of rickettsial disease outbreaks among international partner countries. Workforce development, mentorship, and training are important components in building laboratory capability and capacity to assess risk of and mitigate emerging disease outbreaks. International partnerships that fund cooperative research through mentoring and on-the-job training are successful examples for enhancing infectious disease surveillance. Cooperative research studies between the Naval Medical Research Center's Rickettsial Diseases Research Program (RDRP) and 17 institutes from nine countries among five continents were conducted to address the presence of and the risk for endemic rickettsial diseases. To establish serological and molecular assays in the collaborative institutes, initial training and continued material, and technical support were provided by RDRP. The laboratory methods used in the research studies to detect and identify the rickettsial infections included (1) group-specific IgM and IgG serological assays and (2) molecular assays. Twenty-six cooperative research projects performed between 2008 and 2020 enhanced the capability and capacity of 17 research institutes to estimate risk of rickettsial diseases. These international collaborative studies have led to the recognition and/or confirmation of rickettsial diseases within each of the partner countries. In addition, with the identification of specific pathogen and non-pathogen species, a more accurate risk assessment could be made in surveillance studies using environmental samples. The discoveries from these projects reinforced international cooperation benefiting not only the partner countries but also the scientific community at large through presentations ( = 40) at international scientific meetings and peer-reviewed publications ( = 18). The cooperative research studies conducted in multiple international institutes led to the incorporation of new SOPs and trainings for laboratory procedures; biosafety, biosurety, and biosecurity methods; performance of rickettsia-specific assays; and the identification of known and unknown rickettsial agents through the introduction of new serologic and molecular assays that complemented traditional microbiology methods.
以当前的新冠疫情为例,涉及传染病监测和疫情调查的合作研究严重依赖于合适诊断工具的可用性和有效使用,包括血清学和分子检测方法。在本文中,我们强调利用这些检测方法支持协作性流行病学研究以评估国际伙伴国家之间立克次体病暴发风险的重要性。人员队伍建设、指导和培训是建设实验室能力以评估和减轻新发疾病暴发风险的重要组成部分。通过指导和在职培训资助合作研究的国际伙伴关系是加强传染病监测的成功范例。海军医学研究中心立克次体病研究项目(RDRP)与来自五大洲九个国家的17个机构开展了合作研究,以了解地方性立克次体病的存在情况和风险。为在合作机构中建立血清学和分子检测方法,RDRP提供了初始培训以及持续的物资和技术支持。研究中用于检测和鉴定立克次体感染的实验室方法包括:(1)组特异性IgM和IgG血清学检测;(2)分子检测。2008年至2020年期间开展的26个合作研究项目提高了17个研究机构评估立克次体病风险的能力。这些国际合作研究已促成在每个伙伴国家识别和/或确认立克次体病。此外,通过鉴定特定的病原体和非病原体物种,可以在使用环境样本的监测研究中进行更准确的风险评估。这些项目的发现加强了国际合作,不仅使伙伴国家受益,还通过在国际科学会议上的报告(= 40次)和同行评审出版物(= 18篇)让广大科学界受益。在多个国际机构开展的合作研究促成了针对实验室程序、生物安全、生物保障和生物安保方法、立克次体特异性检测的实施以及通过引入补充传统微生物学方法的新血清学和分子检测方法来鉴定已知和未知立克次体病原体的新标准操作规程和培训。